MicroRNA expression in cytogenetically normal acute myeloid leukemia

New England Journal of Medicine

Volumn 358, Issue 18, 2008, Pages 1919-1928

  Marcucci, Guido ^a   Radmacher, Michael D ^a,b   Maharry, Kati ^a,b   Mrózek, Krzysztof ^a   Ruppert, Amy S ^a,b   Paschka, Peter ^a   Vukosavljevic, Tamara ^a   Whitman, Susan P ^a   Baldus, Claudia D ^c   Langer, Christian ^a   Liu, Chang Gong ^a   Carroll, Andrew J ^d   Powell, Bayard L ^e   Garzon, Ramiro ^a   Croce, Carlo M ^a   Kolitz, Jonathan E ^f   Caligiuri, Michael A ^a   Larson, Richard A ^g   Bloomfield, Clara D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; INTERLEUKIN 1BETA; MICRORNA; TOLL LIKE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COVARIANCE; CYTOGENETICS; DISEASE FREE SURVIVAL; FEMALE; GENE DUPLICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC CODE; GENETIC RISK; HIGH RISK PATIENT; HUMAN; INNATE IMMUNITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

EID: 42949083345     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa074256     Document Type: Article

References (33)

1. K Mrozek NA Heerema CD Bloomfield Cytogenetics in acute leukemia. Blood Rev 18 2004 115 136
2. K Mrozek G Marcucci P Paschka SP Whitman CD Bloomfield Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 109 2007 431 448
3. PJM Valk RGW Verhaak MA Beijen Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350 2004 1617 1628
4. L Bullinger K Dohner E Bair Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350 2004 1605 1616
5. MD Radmacher G Marcucci AS Ruppert Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study. Blood 108 2006 1677 1683
6. K Dohner RF Schlenk M Habdank Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 106 2005 3740 3746
7. G Marcucci K Maharry SP Whitman High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol 25 2007 3337 3343
8. DP Bartel MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 2004 281 297
9. GA Calin CM Croce MicroRNA signatures in human cancers. Nat Rev Cancer 6 2006 857 866
10. Calin GA, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793-801. [Erratum, N Engl J Med 2006;355:533.]
11. N Yanaihara N Caplen E Bowman Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 2006 189 198
12. M Bloomston WL Frankel F Petrocca MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297 2007 1901 1908
13. S Debernardi S Skoulakis G Molloy T Chaplin A Dixon-McIver BD Young MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21 2007 912 916
14. JE Kolitz SL George G Marcucci A randomized comparison of induction therapy for untreated acute myeloid leukemia (AML) in patients <60 years using P-glycoprotein (Pgp) modulation with Valspodar (PSC833): preliminary results of Cancer and Leukemia Group B study 19808. Blood 106 2005 122a 123a
15. JE Kolitz SL George RK Dodge Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B study 9621. J Clin Oncol 22 2004 4290 4301
16. JC Byrd K Mrozek RK Dodge Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100 2002 4325 4336
17. C Thiede C Steudel B Mohr Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99 2002 4326 4335
18. CD Baldus SM Tanner AS Ruppert BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B study. Blood 102 2003 1613 1618
19. G Marcucci CD Baldus AS Ruppert Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. J Clin Oncol 23 2005 9234 9242
20. MD Radmacher LM McShane R Simon A paradigm for class prediction using gene expression profiles. J Comput Biol 9 2002 505 511
21. KD Dahlquist N Salomonis K Vranizan SC Lawlor BR Conklin GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31 2002 19 20
22. CZ Chen L Li HF Lodish DP Bartel MicroRNAs modulate hematopoietic lineage differentiation. Science 303 2004 83 86
23. X Cao SL Pfaff FH Gage A functional study of miR-124 in the developing neural tube. Genes Dev 21 2007 531 536
24. WJ Lukiw Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18 2007 297 300
25. S Akira K Takeda Toll-like receptor signalling. Nat Rev Immunol 4 2004 499 511
26. S Mariathasan DM Monack Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7 2007 31 40
27. J Turzanski M Grundy NH Russell M Pallis Interleukin-1β maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways. Leukemia 18 2004 1662 1670
28. Z Estrov SK Manna D Harris Phenylarsine oxide blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells. Blood 94 1999 2844 2853
29. Z Estrov S Shishodia S Faderl Resveratrol blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102 2003 987 995
30. ML Guzman SJ Neering D Upchurch Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 98 2001 2301 2307
31. AA Awomoyi The human solute carrier family 11 member 1 protein (SLC11A1): linking infections, autoimmunity and cancer? FEMS Immunol Med Microbiol 49 2007 324 329
32. Y Kobayashi C Miyaji H Watanabe Role of macrophage scavenger receptor in endotoxin shock. J Pathol 192 2000 263 272
33. R Kobayashi S Okamura T Ohno Hyperexpression of FcγRI and Toll-like receptor 4 in the intestinal mast cells of Crohn's disease patients. Clin Immunol 125 2007 149 158